Position in ATYR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$835
+$523 QoQ
Shares Held
1,400
+250.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 90 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MCF Advisors LLC holds $1,699,982 across 27 Biotechnology names. ATYR ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,136 | $486,523 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
451 | $224,025 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
27,241 | $154,728 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
2,187 | $119,278 | |
| 5 | MNKD |
Mannkind Corp
|
25,110 | $106,968 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
2,400 | $93,624 | |
| 7 | EYPT |
EyePoint, Inc.
|
6,420 | $91,806 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
415 | $77,721 |
All Filings in ATYR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $835 | 1,400 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $312 | 400 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $313 | 400 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $288 | 400 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||